Collections
Filters
-
Collection Type
-
-
Supplement |
Selected Abstracts from the 2019 NCRI Cancer Conference of National Cancer Research Institute
Organised by the National Cancer Research Institute, which is a partnership of 19 cancer research funders, the NCRI Cancer Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research.
Image: BlackJack3D / iStock-956809720 -
Supplement |
Selected Abstracts from the 2018 NCRI Cancer Conference of National Cancer Research Institute
Organised by the National Cancer Research Institute, which is a partnership of 19 cancer research funders, the NCRI Cancer Conference provides a platform for researchers, clinicians, people affected by cancer and industry representatives to come together to discuss, present and showcase high-quality research.
-
Supplement |
PARP Inhibitors in Ovarian Cancer
In this supplement, the authors comprehensively review molecular and clinical evidence underlying the evolution of poly (ADP-ribose) polymerase (PARP) inhibitors in a journey spanning 50 years, which culminates in the recent licensing approval of the first oral PARP inhibitor, olaparib (Lynparzat™), for BRCA-mutated high-grade serous ovarian cancer.
-
Supplement |
Diagnosing Cancer Earlier: Reviewing the Evidence for Improving Cancer Survival
Proceedings of the 3rd conference of the National Awareness and Early Diagnosis Initiative (NAEDI), held 26th – 27th March 2015, London, UK.
-
Supplement |
Occupational Cancer in Britain
This study was funded by a grant from the UK Health and Safety Executive.
-
Supplement |
The Fraction of Cancer Attributable to Lifestyle and Environmental Factors in the UK in 2010
This supplement was funded by Cancer Research UK.
-
Supplement |
The National Cancer Survivorship Initiative: New and Emerging Evidence on the Ongoing Needs of Cancer Survivors
This supplement was sponsored by Macmillan Cancer Support.
-
-
-
-
Supplement |
Trends and Inequalities in Survival for 20 Cancers in England and Wales 1986-2001: Population-Based Analyses and Clinical Commentaries
This supplement provides important information and commentary on survival rates for the 20 most common cancers diagnosed in England and Wales over a 14-year period from 1986 to 1999.